Main clinical evidence of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers: a systematic review
DOI:
https://doi.org/10.33448/rsd-v11i10.32780Keywords:
Hyperbaric Oxygenation; Lower extremity; Diabetic foot.Abstract
Objective: To analyze the main clinical evidence about the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Methodology: This is a systematic review carried out using the PRISMA method, in the electronic databases PubMed, Scopus and Web of Science, using the following descriptors: “hyperbaric oxygenation”, “diabetes”, “diabetic foot”, “leg ulcer” and “ischemia” Full texts were included, available in Portuguese, English or Spanish, published between January 2016 and December 2021; studies needed to assess the proportion of people with completely healed diabetic foot ulcers in participants randomized to hyperbaric oxygen therapy and in a control group. Results: 08 articles made up the final sample of this study, with a higher frequency of publication in 2019 (n: 03). All studies used the Randomized Clinical Trial methodology, presenting a strong level of evidence (II). Overall, it was found that the rate of amputation in patients undergoing hyperbaric oxygen therapy was lower compared to the standard treatment established in clinical trials. Three studies reported a reduction in ulcer area and five studies showed that hyperbaric oxygen therapy increased the healing rate of diabetic foot ulcers compared to conventional treatment, with statistically significant results. Conclusion: Current evidence shows some evidence of the effectiveness of hyperbaric oxygen therapy in improving the healing of diabetic foot ulcers. Larger and higher quality clinical trials are needed before the implementation of this therapy in routine clinical practice can be justified.
References
Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. N Engl J Med. 376(24), 2367–2375.
Brasil. Ministério da Saúde (MS). (1998). Lei no 9.610, de 19 de fevereiro de 1998, que altera, atualiza e consolida a legislação sobre direitos autorais e dá outras providências. Diário Oficial da União. Brasília: Ministério da Saúde. http://www.planalto.gov.br/ccivil_03/leis/l9610.htm
Brouwer, R. J., Lalieu, R. C., Hoencamp, R., van Hulst, R. A., & Ubbink, D. T. (2020). A systematic review and meta-analysis of hyperbaric oxygen therapy for diabetic foot ulcers with arterial insufficiency. J Vasc Surg. 71(2), 682-692.e1.
Chen, C. Y., Wu, R. W., Hsu, M. C., Hsieh, C. J., & Chou, M. C. (2017). Adjunctive hyperbaric oxygen therapy for healing of chronic diabetic foot ulcers: a randomized controlled trial. J Wound Ostomy Continence Nurs. 44(6), 536-545.
Correia, E. F., Santos, W. C. F., Cunha, B. P. V., Souza, S. L. S., Raposo, B. R. C., Queiroz, L. K. L., et al. (2022). Principais fatores de risco para amputação de membros inferiores em pacientes com pé diabético: uma revisão sistemática. Research, Society and Development. 11(8), e59511831599.
Couto, S. I. S., Silva, D. R. R., Lopes, E. T., Torres, B. K. F., Frazão, M. G. O., Silva, R. M., et al. (2021). Funcionamento da oxigenoterapia hiperbárica e seu uso no tratamento do pé diabético: quais os cuidados de enfermagem? Research, Society and Development. 10(13), e241101320708.
Dong, Y. (2019). Nursing management and efficacy observation of hyperbaric oxygen treatment of diabetic foot ulcer wound. New World of Diabetes. 22(21), 87-88.
Fedorko, L., Bowen, J. M., Jones, W., Oreopoulos, G., Goeree, R., Hopkins, R. B., et al. (2016). Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial. Diabetes Care. 39(3), 392-399.
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res ClinPract. 103, 137-149.
Hassan, M. A., Tamer, T. M., Rageh, A. A., Abou-Zeid, A. M., El-Zaher, E. H. F., & Kenawy, E. R. (2019). Insight into multidrug-resistant microorganisms from microbial infected diabetic foot ulcers. Diabet. Metab. Synd. Clin. Res. Rev. 13(2), 1261–1270.
Kranke, P., Bennett, M. H., Martyn-St James, M., Schnabel, A., Debus, S. E., & Weibel S. (2015). Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015(6), CD004123.
Kumar, A., Shukla, U., Prabhakar, T., & Srivastava, D. (2020). Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers. J Anaesthesiol Clin Pharmacol. 36(2), 213-218.
Lazzarini, P. A., Crews, R. T., van Netten, J. J., Bus, S. A., Fernando, M. E., Chadwick, P. J., et al. (2019). Measuring plantar tissue stress in people with diabetic peripheral neuropathy: a critical concept in diabetic foot management. J Diabetes Sci Technol. 13(5), 869–880.
Lin, X., Xu, Y., Pan, X., Xu, J., Ding, Y., Sun, X., et al. (2020). Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 10(1), 14790.
Löndahl, M., & Boulton, A. J. M. (2020). Hyperbaric oxygen therapy in diabetic foot ulceration: Useless or useful? A battle. Diabetes Metab Res Rev. 36(1), e3233.
Löndahl, M., Fagher, K., & Katzman, P. (2011). Hyperbaric oxygen therapy for chronic diabetic foot ulceration. Diabet Foot J. 14, 39-44. Löndahl, M. (2012). Hyperbaric oxygen therapy as treatment of diabetic foot ulcers. Diabetes Metab Res Rev. 28(1), 78–84.
Martínez, L. J., Martin, R. S. G., & Acker, V. (2019). Debridement and the Diabetic Foot. Foot International. McHugh, M. L. (2012). Interrater reliability: the kappa statistic. Biochemia Medica: 22(3), 276-282.
Memar, M. Y., Yekani, M., Alizadeh, N., & Bannazadeh, B. (2019). Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomedicine & Pharmacotherapy. 109, 440-447.
Nascimento, J. W. A., Roque, G. S. L., Thorpe, L. I. F., Morais, T. N., Santana, F. S. F. S., Silva, E. F. G. C., et al. (2022). Eficácia do mel de grau médico no tratamento de úlceras do pé diabético: uma revisão sistemática. Research, Society and Development. 11(4), e4791142783.
Nascimento, J. W. A., Santos, R. S., Santos, T. M. R., Silva, A. L. B., Rodrigues, L. D. C., Silva, V. W., et al. (2021). Complications associated with intimate partner violence in pregnant women: a systematic review. Int. J. Dev. Res. 11(7), 48924-48928.
Nik Hisamuddin, N. A., Wan Mohd Zahiruddin, W. N., Mohd Yazid, B.m & Rahmah, S. (2019). Use of hyperbaric oxygen therapy (HBOT) in chronic diabetic wound - A randomised trial. Med J Malaysia. 74, 418–424.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et. al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71.
Pati, D.m & Lorusso, L. N. (2018). How to Write a Systematic Review of the Literature. HERD. 11(1), 15-30.
Perren, S., Gatt, A., Papanas, N., & Formosa, C. (2018). Hyperbaric oxygen therapy in ischaemic foot ulcers in type 2 diabetes: a clinical trial. Open Cardiovasc Med J. 12, 80-85.
Ramirez-Acuña, J. M., Cardenas-Cadena, S. A., Marquez-Salas, P. A., Garza-Veloz, I., Perez-Favila, A., Cid-Baez, M. A., et al. (2019). Diabetic foot ulcers: Current advances in antimicrobial therapies and emerging treatments. Antibiotics. 8(4). 193.
Sahni, T., Shweta, G.m & Sapna, V. (2014). Hyperbaric oxygen therapy heals diabetic wounds. Apollo Medicine. 11(1), 27-31.
Salama, S. E., Eldeeb, A. E., Elbarbary, A. H. ,&Adelghany, S. E. (2019). Adjuvant hyperbaric oxygen therapy enhances healing of nonischemic diabetic foot ulcers compared with standard wound care alone. Int J Low Extrem Wounds. 18(1), 75-80.
Santema, K. T. B., Stoekenbroek, R. M., Koelemay, M. J. W., Reekers, J. A., Van Dortmont, L. M. C., Oomen, A., et al. (2018). Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care. 41, 112-119.
Schaper, N. C., Van Netten, J. J., Apelqvist, J., Bus, S. A., Hinchliffe, R. J., Lipsky, B. A., et al. (2020). Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 36(S1), e3266.
Sharma, R., Sharma, S. K., Mudgal, S. K., Jelly, P., & Thakur, K. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta- analysis of controlled clinical trials. Sci Rep. 11(1), 2189.
Stillwell, S., Fineout-Overholt, E., Melnyk, B. M., & Wiliamson, K. M. (2010). Evidence– based practice: step by step. Am J Nurs; 110(5), 41-47.
Stoekenbroek, R. M., Santema, T. B., Legemate, D. A., Ubbink, D. T., van den Brink, A., & Koelemay, M. J. W. (2014). Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg. 47(6), 647-655.
Tiaka, E. K., Papanas, N., Manolakis, A. C., & Maltezos, E. (2012). The role of hyperbaric oxygen in the treatment of diabetic foot ulcers. Angiology. 4, 302– 314.
Yazdanpanah, L. (2015). Literature review on the management of diabetic foot ulcer. World J. Diabetes. 6, 37.
Yazdanpanah, L., Nasiri, M., & Adarvishi S. (2015). Literature Review on the management of diabetic foot ulcer. World J Diabetes. 6, 37–53.
Zhang, Y., Cramb, S., McPhail, S. M., Pacella, R. E., Van Netten, J. J., Cheng, Q., et al. (2021). Factors associated with healing of diabetes-related foot ulcers: observations from a large prospective real-world cohort. Diabetes Care. 44(7), e143–e5.
Zhao, D., Luo, S., Xu, W., Hu, J., Lin, S., & Wang, N. (2017). Efficacy and Safety of Hyperbaric Oxygen Therapy Used in Patients With Diabetic Foot: A Meta-analysis of Randomized Clinical Trials. Clinical Therapeutics. 39(10), 2088-2094.e2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Letícia de Sousa Eduardo; Maria Eduarda Gonçalves Farias; Camila Carvalho de Oliveira; Juliana Alves de Souza; Simone Barbosa da Silva Ferreira; Cynthia Lopes Ferreira; José William Araújo do Nascimento
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
